Cargando…
Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience
GOAL: The goal of this study was the determination of the effects in treatment of early stage (<IIB) and locally advanced stages (≥IIB) of uterine cervical carcinoma by using MRI. MATERIAL AND METHODS: The study was a prospective, comparative, analytical, and observational and included 74 patient...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402375/ https://www.ncbi.nlm.nih.gov/pubmed/28484296 http://dx.doi.org/10.5455/aim.2017.25.39-43 |
_version_ | 1783231220329480192 |
---|---|
author | Sofic, Amela Husic-Selimovic, Azra Beslic, Nermina Rasic, Azra Begic, Dzenana Tomic-Cica, Anja Imsirevic, Nejira |
author_facet | Sofic, Amela Husic-Selimovic, Azra Beslic, Nermina Rasic, Azra Begic, Dzenana Tomic-Cica, Anja Imsirevic, Nejira |
author_sort | Sofic, Amela |
collection | PubMed |
description | GOAL: The goal of this study was the determination of the effects in treatment of early stage (<IIB) and locally advanced stages (≥IIB) of uterine cervical carcinoma by using MRI. MATERIAL AND METHODS: The study was a prospective, comparative, analytical, and observational and included 74 patients with cervical cancer (PH confirmed). All 74 patients have initially gone through the pre-therapeutic MRI to determine the tumour FIGO stage. At a renewal of the initial MRI findings, patients were divided into two study groups: group A and group B. Group A consisted from 39 patients with early-stage cervical carcinoma (<IIB) and group B comprised from 35 patients with locally advanced stage (≥IIB). Postterapeutic MRI control, were perfomed in both group (A and B). Further MRI examinations were set for the patients from both groups. RESULTS: An analysis of treatment outcomes in group A showed that most patients had no local recurrence or residuum disease in 89.7%, while local recurrence was observed in only 10.3% cases. An analysis of treatment outcomes in group B showed that most patients had complete regression after local chemoradiotherapy in 68.8%, while 25.7% of patients had local progression of the disease, while the 5.7% cases recorded partial local tumour regression(p<0.05). It has been shown that a complete local regression was more frequent in the case of squamous cell carcinoma in 74.2% vs 25% in adenocarcinoma cases. Also local and partial regression was observed more frequently in the case of squamous cell carcinoma in 6.5% compared to 0% in adenocarcinoma, while progression was more common in adenocarcinoma at 75% compared to 19.4% for squamous cell (p<0.05). MRI results showed positive outcome of treatment group A and B in our study, showed a statistically significant difference in favour of group A (89.7%) compared to group B 68.8% (p<0.05). CONCLUSION: The results obtained from our studies show that early stage cervical cancer (<IIB) shows a better outcome in treatment of advanced stages (≥IIB). In the treatment of advanced stages (≥IIB), concomitant radio chemotherapy shows significant results in terms of complete tumour regression, especially in squamous cell type of cervical cancer. |
format | Online Article Text |
id | pubmed-5402375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | AVICENA, d.o.o., Sarajevo |
record_format | MEDLINE/PubMed |
spelling | pubmed-54023752017-05-08 Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience Sofic, Amela Husic-Selimovic, Azra Beslic, Nermina Rasic, Azra Begic, Dzenana Tomic-Cica, Anja Imsirevic, Nejira Acta Inform Med Original Paper GOAL: The goal of this study was the determination of the effects in treatment of early stage (<IIB) and locally advanced stages (≥IIB) of uterine cervical carcinoma by using MRI. MATERIAL AND METHODS: The study was a prospective, comparative, analytical, and observational and included 74 patients with cervical cancer (PH confirmed). All 74 patients have initially gone through the pre-therapeutic MRI to determine the tumour FIGO stage. At a renewal of the initial MRI findings, patients were divided into two study groups: group A and group B. Group A consisted from 39 patients with early-stage cervical carcinoma (<IIB) and group B comprised from 35 patients with locally advanced stage (≥IIB). Postterapeutic MRI control, were perfomed in both group (A and B). Further MRI examinations were set for the patients from both groups. RESULTS: An analysis of treatment outcomes in group A showed that most patients had no local recurrence or residuum disease in 89.7%, while local recurrence was observed in only 10.3% cases. An analysis of treatment outcomes in group B showed that most patients had complete regression after local chemoradiotherapy in 68.8%, while 25.7% of patients had local progression of the disease, while the 5.7% cases recorded partial local tumour regression(p<0.05). It has been shown that a complete local regression was more frequent in the case of squamous cell carcinoma in 74.2% vs 25% in adenocarcinoma cases. Also local and partial regression was observed more frequently in the case of squamous cell carcinoma in 6.5% compared to 0% in adenocarcinoma, while progression was more common in adenocarcinoma at 75% compared to 19.4% for squamous cell (p<0.05). MRI results showed positive outcome of treatment group A and B in our study, showed a statistically significant difference in favour of group A (89.7%) compared to group B 68.8% (p<0.05). CONCLUSION: The results obtained from our studies show that early stage cervical cancer (<IIB) shows a better outcome in treatment of advanced stages (≥IIB). In the treatment of advanced stages (≥IIB), concomitant radio chemotherapy shows significant results in terms of complete tumour regression, especially in squamous cell type of cervical cancer. AVICENA, d.o.o., Sarajevo 2017-03 /pmc/articles/PMC5402375/ /pubmed/28484296 http://dx.doi.org/10.5455/aim.2017.25.39-43 Text en Copyright: © 2017 Amela Sofic, Azra Husic-Selimovic, Nermina Beslic, Azra Rasic, Dzenana Begic, Anja Tomic-Cica, Nejira Imsirevic http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Sofic, Amela Husic-Selimovic, Azra Beslic, Nermina Rasic, Azra Begic, Dzenana Tomic-Cica, Anja Imsirevic, Nejira Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience |
title | Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience |
title_full | Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience |
title_fullStr | Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience |
title_full_unstemmed | Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience |
title_short | Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience |
title_sort | effects of treatment of uterine cervical carcinoma monitored by magnetic resonance imaging - sarajevo experience |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402375/ https://www.ncbi.nlm.nih.gov/pubmed/28484296 http://dx.doi.org/10.5455/aim.2017.25.39-43 |
work_keys_str_mv | AT soficamela effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience AT husicselimovicazra effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience AT beslicnermina effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience AT rasicazra effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience AT begicdzenana effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience AT tomiccicaanja effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience AT imsirevicnejira effectsoftreatmentofuterinecervicalcarcinomamonitoredbymagneticresonanceimagingsarajevoexperience |